United Kingdom · Question · Written question
UIN 18585
Innovation and Technology: Obesity
Introduced
14 July 2026
Last action
20 July 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 July 2026
Summary
To ask the Secretary of State for Science, Innovation and Technology, pursuant to the Answer of 13 July 2026 to Question 15321 on Innovation and Technology: Obesity, whether the evaluation activity will be independent of Eli Lilly and Company; whether it
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
14 July 2026
Written question
To ask the Secretary of State for Science, Innovation and Technology, pursuant to the Answer of 13 July 2026 to Question 15321 on Innovation and Technology: Obesity, whether the evaluation activity will be independent of Eli Lilly and Company; whether it
Source: Commons
20 July 2026
Answer
The Obesity Pathway Innovation Programme evaluation has been commissioned independently through the National Institute for Health and Care Research and is entirely independent of Eli Lilly and Company. The evaluation team is currently working with funded ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- · Department for Science, Innovation and Technology · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-07-14/18585
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1927588
- uk · wq-1927588 · source updated 20 July 2026